Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 76

1.

Pegylated interferon α plus ribavirin for the treatment of chronic hepatitis C: a multicentre independent study supported by the Italian Drug Agency.

Rosina F, Tosti ME, Borghesio E, Masocco M, Mele A, Coppola C, Milella M, Borgia G, Andreone P, Koch M, Zignego AL, Romano M, Carrara M, Almasio PL, Azzola E, Nardone G, Benedetti A, Carosi G, Mazzotta F, Sagnelli E, Rizzetto M; AIFA Study Group; Italian Association for the Study of the Liver (AISF); Italian Society for Infectious and Tropical Diseases (SIMIT); Italian Association of Hospital Gastroenterologists (AIGO); Italian Society of Gastroenterology (SIGE); Italian Association for the Study of the Liver AISF; Italian Society for Infectious and Tropical Diseases SIMIT; Italian Association of Hospital Gastroenterologists AIGO; Italian Society of Gastroenterology SIGE.

Dig Liver Dis. 2014 Sep;46(9):826-32. doi: 10.1016/j.dld.2014.05.014. Epub 2014 Jun 28.

PMID:
24986781
2.

Increase of ribavirin dose improves sustained virological response in HCV-genotype 1 patients with a partial response to peg-interferon and ribavirin.

Conti F, Vukotic R, Lorenzini S, Riili A, Cursaro C, Scuteri A, Loggi E, Galli S, Furlini G, Bernardi M, Andreone P.

Ann Hepatol. 2014 Mar-Apr;13(2):196-203.

PMID:
24552861
3.

Virus-specific immune response in HBeAg-negative chronic hepatitis B: relationship with clinical profile and HBsAg serum levels.

Loggi E, Bihl FK, Cursaro C, Granieri C, Galli S, Brodosi L, Furlini G, Bernardi M, Brander C, Andreone P.

PLoS One. 2013 Jun 4;8(6):e65327. doi: 10.1371/journal.pone.0065327. Print 2013.

4.

Pathway-based analysis of primary biliary cirrhosis genome-wide association studies.

Kar SP, Seldin MF, Chen W, Lu E, Hirschfield GM, Invernizzi P, Heathcote J, Cusi D; Italian PBC Genetics Study Group, Gershwin ME, Siminovitch KA, Amos CI.

Genes Immun. 2013 Apr;14(3):179-86. doi: 10.1038/gene.2013.1. Epub 2013 Feb 7.

5.

Patterns of HCV-RNA and HCV core antigen in the early monitoring of standard treatment for chronic hepatitis C.

Loggi E, Cursaro C, Scuteri A, Grandini E, Panno AM, Galli S, Furlini G, Bernardi M, Galli C, Andreone P.

J Clin Virol. 2013 Mar;56(3):207-11. doi: 10.1016/j.jcv.2012.11.012. Epub 2012 Dec 13.

PMID:
23245628
6.

Differential boosting of innate and adaptive antiviral responses during pegylated-interferon-alpha therapy of chronic hepatitis B.

Micco L, Peppa D, Loggi E, Schurich A, Jefferson L, Cursaro C, Panno AM, Bernardi M, Brander C, Bihl F, Andreone P, Maini MK.

J Hepatol. 2013 Feb;58(2):225-33. doi: 10.1016/j.jhep.2012.09.029. Epub 2012 Oct 6.

PMID:
23046671
7.

Immunochip analyses identify a novel risk locus for primary biliary cirrhosis at 13q14, multiple independent associations at four established risk loci and epistasis between 1p31 and 7q32 risk variants.

Juran BD, Hirschfield GM, Invernizzi P, Atkinson EJ, Li Y, Xie G, Kosoy R, Ransom M, Sun Y, Bianchi I, Schlicht EM, Lleo A, Coltescu C, Bernuzzi F, Podda M, Lammert C, Shigeta R, Chan LL, Balschun T, Marconi M, Cusi D, Heathcote EJ, Mason AL, Myers RP, Milkiewicz P, Odin JA, Luketic VA, Bacon BR, Bodenheimer HC Jr, Liakina V, Vincent C, Levy C, Franke A, Gregersen PK, Bossa F, Gershwin ME, deAndrade M, Amos CI; Italian PBC Genetics Study Group, Lazaridis KN, Seldin MF, Siminovitch KA.

Hum Mol Genet. 2012 Dec 1;21(23):5209-21. doi: 10.1093/hmg/dds359. Epub 2012 Aug 29.

8.

Randomised study comparing 48 and 96 weeks peginterferon α-2a therapy in genotype D HBeAg-negative chronic hepatitis B.

Lampertico P, Viganò M, Di Costanzo GG, Sagnelli E, Fasano M, Di Marco V, Boninsegna S, Farci P, Fargion S, Giuberti T, Iannacone C, Regep L, Massetto B, Facchetti F, Colombo M; PegBeLiver Study Group.

Gut. 2013 Feb;62(2):290-8. doi: 10.1136/gutjnl-2011-301430. Epub 2012 Aug 2.

PMID:
22859496
9.

A combined free flow electrophoresis and DIGE approach to compare proteins in complex biological samples.

Fung KY, Cursaro C, Lewanowitsch T, Cosgrove L, Hoffmann P.

Methods Mol Biol. 2012;869:135-46. doi: 10.1007/978-1-61779-821-4_12.

PMID:
22585483
10.

Classical HLA-DRB1 and DPB1 alleles account for HLA associations with primary biliary cirrhosis.

Invernizzi P, Ransom M, Raychaudhuri S, Kosoy R, Lleo A, Shigeta R, Franke A, Bossa F, Amos CI, Gregersen PK, Siminovitch KA, Cusi D, de Bakker PI, Podda M, Gershwin ME, Seldin MF; Italian PBC Genetics Study Group.

Genes Immun. 2012 Sep;13(6):461-8. doi: 10.1038/gene.2012.17. Epub 2012 May 10.

11.

Silybin combined with phosphatidylcholine and vitamin E in patients with nonalcoholic fatty liver disease: a randomized controlled trial.

Loguercio C, Andreone P, Brisc C, Brisc MC, Bugianesi E, Chiaramonte M, Cursaro C, Danila M, de Sio I, Floreani A, Freni MA, Grieco A, Groppo M, Lazzari R, Lobello S, Lorefice E, Margotti M, Miele L, Milani S, Okolicsanyi L, Palasciano G, Portincasa P, Saltarelli P, Smedile A, Somalvico F, Spadaro A, Sporea I, Sorrentino P, Vecchione R, Tuccillo C, Del Vecchio Blanco C, Federico A.

Free Radic Biol Med. 2012 May 1;52(9):1658-65. doi: 10.1016/j.freeradbiomed.2012.02.008. Epub 2012 Feb 15.

PMID:
22343419
12.

Serum hepatitis B surface antigen monitoring in long-term lamivudine-treated hepatitis B virus patients.

Gramenzi A, Loggi E, Micco L, Cursaro C, Fiorino S, Galli S, Gitto S, Galli C, Furlini G, Bernardi M, Andreone P.

J Viral Hepat. 2011 Oct;18(10):e468-74. doi: 10.1111/j.1365-2893.2011.01473.x. Epub 2011 Jun 1.

PMID:
21914065
13.

A combined free-flow electrophoresis and DIGE approach to identify proteins regulated by butyrate in HT29 cells.

Fung KY, Cursaro C, Lewanowitsch T, Brierley GV, McColl SR, Lockett T, Head R, Hoffmann P, Cosgrove L.

Proteomics. 2011 Mar;11(5):964-71. doi: 10.1002/pmic.201000429. Epub 2011 Jan 31.

PMID:
21280223
14.

Vitamins in the treatment of chronic viral hepatitis.

Fiorino S, Conti F, Gramenzi A, Loggi E, Cursaro C, Di Donato R, Micco L, Gitto S, Cuppini A, Bernardi M, Andreone P.

Br J Nutr. 2011 Apr;105(7):982-9. doi: 10.1017/S0007114510004629. Epub 2011 Jan 24. Review.

PMID:
21255469
15.

Pharmacokinetics and efficacy of intravenous or intramuscular hepatitis B immunoglobulins in prophylaxis of hepatitis B after liver transplantation.

Marzano A, Marengo A, Andreone P, Volpes R, Canova D, Cursaro C, Riili A, Fiorentino B, Bacci M, Guazzini S, Burra P.

Minerva Med. 2010 Dec;101(6):373-83.

PMID:
21196896
16.

Role of contrast-enhanced ultrasonography in primary hepatic lymphoma.

Foschi FG, Dall'Aglio AC, Marano G, Lanzi A, Savini P, Piscaglia F, Serra C, Cursaro C, Bernardi M, Andreone P, Stefanini GF.

J Ultrasound Med. 2010 Sep;29(9):1353-6.

17.

Immunological modifications during treatment with thymosin alpha1 plus antiviral therapy in chronic hepatitis C.

Grandini E, Cannoletta F, Scuteri A, Fortini C, Loggi E, Cursaro C, Riili A, Di Donato R, Gramenzi A, Bernardi M, Andreone P.

Ann N Y Acad Sci. 2010 Apr;1194:147-52. doi: 10.1111/j.1749-6632.2010.05461.x.

PMID:
20536463
18.

Ketoprofen, peginterferon 2a and ribavirin for genotype 1 chronic hepatitis C: a phase II study.

Gramenzi A, Cursaro C, Margotti M, Balsano C, Spaziani A, Anticoli S, Loggi E, Salerno M, Galli S, Furlini G, Bernardi M, Andreone P.

World J Gastroenterol. 2009 Dec 21;15(47):5946-52.

19.

Hepatitis C Virus-related chronic liver disease in elderly patients: an Italian cross-sectional study.

Gramenzi A, Conti F, Felline F, Cursaro C, Riili A, Salerno M, Gitto S, Micco L, Scuteri A, Andreone P, Bernardi M.

J Viral Hepat. 2010 May;17(5):360-6. doi: 10.1111/j.1365-2893.2009.01189.x. Epub 2009 Sep 16.

PMID:
19758274
20.

Hepatocellular carcinoma in patients with cryptogenic cirrhosis.

Giannini EG, Marabotto E, Savarino V, Trevisani F, di Nolfo MA, Del Poggio P, Benvegnù L, Farinati F, Zoli M, Borzio F, Caturelli E, Chiaramonte M; Italian Liver Cancer (ITALICA) Group.

Clin Gastroenterol Hepatol. 2009 May;7(5):580-5. doi: 10.1016/j.cgh.2009.01.001.

PMID:
19418607
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk